Organization
University of Toronto, Toronto, ON, Canada
5 abstracts
Abstract
Phase IB study of tovorafenib for children with relapsed/recurrent low-grade gliomas and other MAPK pathway activated tumors.Org: Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Children's Hospital of Philidelphia, St. Louis Children's Hospital, University of Florida-Health Cancer Center, Orlando Health, Orlando, FL, Massachusetts General Hospital,
Abstract
canadian adalimumab post-marketing observational epidemiological study assessing the effectiveness of adalimumab vs non-biologic dmards in psoriatic arthritis (COMPLETE-PSA): 12-month effectiveness dataOrg: Memorial University of Newfoundland, St. John’s, Laval University, Centre Hospitalier de l’Université Laval, Quebec, University of Toronto, Toronto, ON, Canada, Centre Hhospitalier de l’Université de Montréal, Montreal, McMaster University, Hamilton, ON, Canada,
Abstract
ASSOCIATION OF ANKYLOSING SPONDYLITIS SUSCEPTIBILITY SNPS FROM RECENT GWAS IN A CANADIAN PSORIATIC ARTHRITIS COHORT Org: Memorial University of Newfoundland, St. John's, Canada, University of Toronto, Toronto, ON, Canada, University of Alberta, Edmonton, Canada, Newfound Genomics Inc., St. John's, Canada,
Abstract
A PROGRESSIVE STEPWISE ACCRUAL OF T CELL ABNORMALITIES MARKS THE TRANSITION FROM BENIGN TO SYMPTOMATIC AUTOIMMUNITY Org: University Health Network, University of Toronto, Toronto, ON, Canada, Lakeridge Health Center, Oshawa, The Hospital for Sick Children, Toronto, Canada,
Abstract
AN EVALUATION OF THE POTENTIAL EFFECTS OF A NATIONAL CONSENSUS STATEMENT ON OPTIMAL TREATMENT OF EARLY RHEUMATOID ARTHRITIS IN ONTARIO Org: McGill University, Montreal, QC, Canada, University of Toronto, Toronto, ON, Canada, McMaster University, Hamilton, ON, Canada, Institute for Clinical and Evaluative Sciences, Toronto, University of Western Ontarion, London,